Table 1.
COVID-19 period definitions for assessing tuberculosis treatment outcomes prior to and during COVID-19 in Peru.
| TB treatment regimen | Regimen treatment time | TB care pre-COVID-19 | TB care partially during COVID-19 | TB care fully during COVID-19 |
|---|---|---|---|---|
| 2HREZ/4(HR)3a | 6 months | Diagnosed 1 Jan 2018–15 Sep 2019 (≥6 months prior to start of COVID-19 restrictions) | Diagnosed 16 Sep 2019–15 Mar 2020 | Diagnosed 16 Mar 2020–16 Mar 2021 |
| 2HREZ/7HRb | 9 months | Diagnosed 1 Jan 2018–15 June 2019 (≥9 months prior to start of COVID-19 restrictions) | Diagnosed 16 June 2019–15 Mar 2020 | |
| 2HREZ/10HRc | 12 months | Diagnosed 1 Jan 2018–15 Mar 2019 (≥12 months prior to start of COVID-19 restrictions) | Diagnosed 16 Mar 2019–15 Mar 2020 |
H = isoniazid, R = rifampicin, E = ethambutol, Z = pyrazinamide.
a
Daily∗ HREZ for 2 months, HR for 4 months on 3 days per week (Standard DS-TB regimen). ∗Except Sundays.37
b
Daily∗ HREZ for 2 months, daily∗ HR for 7 months (DS-TB regimen in people living with HIV). ∗Except Sundays.37
c
Daily∗ HREZ for 2 months, daily∗ HR for 10 months (Extrapulmonary DS-TB regimen). ∗Except Sundays.37